Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 734

1.

Linear and exponential sunscreen behaviours as an explanation for observed discrepancies in sun protection factor testing.

Trullàs C, Granger C, Lim HW, Krutmann J, Masson P.

Photodermatol Photoimmunol Photomed. 2019 Aug 3. doi: 10.1111/phpp.12500. [Epub ahead of print]

PMID:
31376288
2.

Inhibition of IL-23 mediated inflammation with a novel small molecule inverse agonist of RORgt.

Gauld S, Jacquet S, Gauvin D, Wallace C, Wang Y, McCarthy R, Goess C, Leys L, Huang S, Su Z, Edelmayer R, Wetter J, Salte K, McGaraughty S, Argiriadi M, Honore P, Luccarini JM, Bressac D, Desino K, Breinlinger E, Cusack K, Potin D, Kort M, Masson P.

J Pharmacol Exp Ther. 2019 Aug 2. pii: jpet.119.258046. doi: 10.1124/jpet.119.258046. [Epub ahead of print]

3.

Density measurement of liquid 22MnB5 by aerodynamic levitation.

Le Maux D, Courtois M, Pierre T, Lamien B, Le Masson P.

Rev Sci Instrum. 2019 Jul;90(7):074904. doi: 10.1063/1.5089620.

PMID:
31370501
4.

Analysis of physical exercise in cardiac patients following cardiovascular rehabilitation.

Racodon M, Pezé T, Masson P.

Acta Cardiol. 2019 Jul 17:1-6. doi: 10.1080/00015385.2019.1639269. [Epub ahead of print]

PMID:
31314680
5.

Time-course of human cholinesterases-catalyzed competing substrate kinetics.

Mukhametgalieva AR, Aglyamova AR, Lushchekina SV, Goličnik M, Masson P.

Chem Biol Interact. 2019 Sep 1;310:108702. doi: 10.1016/j.cbi.2019.06.015. Epub 2019 Jun 24.

PMID:
31247192
6.

Time-course of enzyme-catalyzed competing substrate degradation for michaelian behavior and for enzymes showing activation/inhibition by excess substrate.

Goličnik M, Masson P.

Chem Biol Interact. 2019 Aug 25;309:108704. doi: 10.1016/j.cbi.2019.06.017. Epub 2019 Jun 15.

PMID:
31211951
7.

The four-helix bundle in cholinesterase dimers: Structural and energetic determinants of stability.

Novichkova DA, Lushchekina SV, Dym O, Masson P, Silman I, Sussman JL.

Chem Biol Interact. 2019 Aug 25;309:108699. doi: 10.1016/j.cbi.2019.06.012. Epub 2019 Jun 13.

PMID:
31202688
8.

New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease.

Zueva I, Dias J, Lushchekina S, Semenov V, Mukhamedyarov M, Pashirova T, Babaev V, Nachon F, Petrova N, Nurullin L, Zakharova L, Ilyin V, Masson P, Petrov K.

Neuropharmacology. 2019 Sep 1;155:131-141. doi: 10.1016/j.neuropharm.2019.05.025. Epub 2019 May 25.

PMID:
31132435
9.

Real-Life Efficacy of Osimertinib in Pretreated Octogenarian Patients with T790M-Mutated Advanced Non-small Cell Lung Cancer.

Auliac JB, Saboundji K, Andre M, Madelaine J, Quere G, Masson P, Vergnenegre A, Lamy R, Raymond S, Chiappa AM, Hauss PA, Fournel P, Corre R, Chouaid C.

Target Oncol. 2019 Jun;14(3):307-314. doi: 10.1007/s11523-019-00646-4.

PMID:
31119481
10.

Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists.

Amaudrut J, Argiriadi MA, Barth M, Breinlinger EC, Bressac D, Broqua P, Calderwood DJ, Chatar M, Cusack KP, Gauld SB, Jacquet S, Kamath RV, Kort ME, Lepais V, Luccarini JM, Masson P, Montalbetti C, Mounier L, Potin D, Poupardin O, Rouaud S, Spitzer L, Wallace CD.

Bioorg Med Chem Lett. 2019 Jul 15;29(14):1799-1806. doi: 10.1016/j.bmcl.2019.05.015. Epub 2019 May 9.

PMID:
31101472
11.

Computer-designed active human butyrylcholinesterase double mutant with a new catalytic triad.

Grigorenko BL, Novichkova DA, Lushchekina SV, Zueva IV, Schopfer LM, Nemukhin AV, Varfolomeev SD, Lockridge O, Masson P.

Chem Biol Interact. 2019 Jun 1;306:138-146. doi: 10.1016/j.cbi.2019.04.019. Epub 2019 Apr 19.

PMID:
31009643
12.

Feedback on the usefulness of an illustrated guidebook in an anatomical dissection course.

Bellier A, Cavalie G, Masson P, Palombi O, Chaffanjon P.

Surg Radiol Anat. 2019 Mar 8. doi: 10.1007/s00276-019-02194-y. [Epub ahead of print]

PMID:
30850863
13.

Absolute risk and risk factors for stroke mortality in patients with end-stage kidney disease (ESKD): population-based cohort study using data linkage.

De La Mata NL, Alfaro-Ramirez M, Kelly PJ, Masson P, Al-Shahi Salman R, Webster AC.

BMJ Open. 2019 Feb 22;9(2):e026263. doi: 10.1136/bmjopen-2018-026263.

14.

Death From Stroke in End-Stage Kidney Disease.

De La Mata NL, Masson P, Al-Shahi Salman R, Kelly PJ, Webster AC.

Stroke. 2019 Feb;50(2):487-490. doi: 10.1161/STROKEAHA.118.023644.

PMID:
30591007
15.

Structural stability of human butyrylcholinesterase under high hydrostatic pressure.

Kangur L, Timpmann K, Zeller D, Masson P, Peters J, Freiberg A.

Biochim Biophys Acta Proteins Proteom. 2019 Feb;1867(2):107-113. doi: 10.1016/j.bbapap.2018.11.001. Epub 2018 Nov 7.

PMID:
30414450
16.

3D structure of the natural tetrameric form of human butyrylcholinesterase as revealed by cryoEM, SAXS and MD.

Boyko KM, Baymukhametov TN, Chesnokov YM, Hons M, Lushchekina SV, Konarev PV, Lipkin AV, Vasiliev AL, Masson P, Popov VO, Kovalchuk MV.

Biochimie. 2019 Jan;156:196-205. doi: 10.1016/j.biochi.2018.10.017. Epub 2018 Oct 29.

17.

Purification of recombinant human butyrylcholinesterase on Hupresin®.

Lockridge O, David E, Schopfer LM, Masson P, Brazzolotto X, Nachon F.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Dec 1;1102-1103:109-115. doi: 10.1016/j.jchromb.2018.10.026. Epub 2018 Oct 25.

PMID:
30384187
18.

Combination delivery of two oxime-loaded lipid nanoparticles: Time-dependent additive action for prolonged rat brain protection.

Pashirova TN, Braïki A, Zueva IV, Petrov KA, Babaev VM, Burilova EA, Samarkina DA, Rizvanov IK, Souto EB, Jean L, Renard PY, Masson P, Zakharova LY, Sinyashin OG.

J Control Release. 2018 Nov 28;290:102-111. doi: 10.1016/j.jconrel.2018.10.010. Epub 2018 Oct 9.

PMID:
30308259
19.

Mixed cationic liposomes for brain delivery of drugs by the intranasal route: The acetylcholinesterase reactivator 2-PAM as encapsulated drug model.

Pashirova TN, Zueva IV, Petrov KA, Lukashenko SS, Nizameev IR, Kulik NV, Voloshina AD, Almasy L, Kadirov MK, Masson P, Souto EB, Zakharova LY, Sinyashin OG.

Colloids Surf B Biointerfaces. 2018 Nov 1;171:358-367. doi: 10.1016/j.colsurfb.2018.07.049. Epub 2018 Jul 24.

PMID:
30059851
20.

Catalytic bioscavengers against organophosphorus agents: mechanistic issues of self-reactivating cholinesterases.

Lushchekina S, Masson P.

Toxicology. 2018 Nov 1;409:91-102. doi: 10.1016/j.tox.2018.07.020. Epub 2018 Jul 26.

PMID:
30056174
21.
22.

Organophosphorus poisoning in animals and enzymatic antidotes.

Poirier L, Jacquet P, Plener L, Masson P, Daudé D, Chabrière E.

Environ Sci Pollut Res Int. 2018 Jun 29. doi: 10.1007/s11356-018-2465-5. [Epub ahead of print]

PMID:
29959732
23.

Immunosuppressive treatment for proliferative lupus nephritis.

Tunnicliffe DJ, Palmer SC, Henderson L, Masson P, Craig JC, Tong A, Singh-Grewal D, Flanc RS, Roberts MA, Webster AC, Strippoli GF.

Cochrane Database Syst Rev. 2018 Jun 29;6:CD002922. doi: 10.1002/14651858.CD002922.pub4. Review.

24.

The revised EEMCO guidance for the in vivo measurement of water in the skin.

Berardesca E, Loden M, Serup J, Masson P, Rodrigues LM.

Skin Res Technol. 2018 Aug;24(3):351-358. doi: 10.1111/srt.12599. Epub 2018 Jun 20.

PMID:
29923639
25.

Water structure changes in oxime-mediated reactivation process of phosphorylated human acetylcholinesterase.

Zueva IV, Lushchekina SV, Masson P.

Biosci Rep. 2018 Jun 29;38(3). pii: BSR20180609. doi: 10.1042/BSR20180609. Print 2018 Jun 29.

26.

Optimization of Cholinesterase-Based Catalytic Bioscavengers Against Organophosphorus Agents.

Lushchekina SV, Schopfer LM, Grigorenko BL, Nemukhin AV, Varfolomeev SD, Lockridge O, Masson P.

Front Pharmacol. 2018 Mar 13;9:211. doi: 10.3389/fphar.2018.00211. eCollection 2018.

27.

Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) α/γ/δ Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate.

Boubia B, Poupardin O, Barth M, Binet J, Peralba P, Mounier L, Jacquier E, Gauthier E, Lepais V, Chatar M, Ferry S, Thourigny A, Guillier F, Llacer J, Amaudrut J, Dodey P, Lacombe O, Masson P, Montalbetti C, Wettstein G, Luccarini JM, Legendre C, Junien JL, Broqua P.

J Med Chem. 2018 Mar 22;61(6):2246-2265. doi: 10.1021/acs.jmedchem.7b01285. Epub 2018 Feb 27.

PMID:
29446942
28.

Novel Alkali Activation of Titanium Substrates To Grow Thick and Covalently Bound PMMA Layers.

Reggente M, Masson P, Dollinger C, Palkowski H, Zafeiratos S, Jacomine L, Passeri D, Rossi M, Vrana NE, Pourroy G, Carradò A.

ACS Appl Mater Interfaces. 2018 Feb 14;10(6):5967-5977. doi: 10.1021/acsami.7b17008. Epub 2018 Jan 30.

PMID:
29338177
29.

C-547, a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase: Pharmacokinetic and pharmacodynamic studies.

Petrov K, Zueva I, Kovyazina I, Sedov I, Lushchekina S, Kharlamova A, Lenina O, Koshkin S, Shtyrlin Y, Nikolsky E, Masson P.

Neuropharmacology. 2018 Mar 15;131:304-315. doi: 10.1016/j.neuropharm.2017.12.034. Epub 2017 Dec 24.

PMID:
29277489
30.

On the Potential of Hydrogen-Powered Hydraulic Pumps for Soft Robotics.

Desbiens AB, Bigué JL, Véronneau C, Masson P, Iagnemma K, Plante JS.

Soft Robot. 2017 Dec;4(4):367-378. doi: 10.1089/soro.2016.0071. Epub 2017 Jul 5.

PMID:
29251565
31.

Metabolomics of tomato xylem sap during bacterial wilt reveals Ralstonia solanacearum produces abundant putrescine, a metabolite that accelerates wilt disease.

Lowe-Power TM, Hendrich CG, von Roepenack-Lahaye E, Li B, Wu D, Mitra R, Dalsing BL, Ricca P, Naidoo J, Cook D, Jancewicz A, Masson P, Thomma B, Lahaye T, Michael AJ, Allen C.

Environ Microbiol. 2018 Apr;20(4):1330-1349. doi: 10.1111/1462-2920.14020. Epub 2017 Dec 22.

32.

[Therapeutic strategies in patients undergoing surgery for non-small cell lung cancer. Results of the ESCAP-2011-CPHG study, promoted by the French College of General Hospital Respiratory Physicians (CPHG)].

Pinquié F, Goupil F, Oster JP, Dixmier A, Renault PA, Lévy A, Mathieu JP, Paillot N, Goutorbe FC, Masson P, Molinier O, Debieuvre D, Grivaux M.

Rev Mal Respir. 2017 Nov;34(9):976-990. doi: 10.1016/j.rmr.2017.05.002. Epub 2017 Nov 15. French.

PMID:
29150179
33.

Quantitative Trait Loci for Root Growth Response to Cadaverine in Arabidopsis.

Gibbs NM, Rouhana LV, Masson PH.

Methods Mol Biol. 2018;1694:233-256. doi: 10.1007/978-1-4939-7398-9_22.

PMID:
29080172
34.

Molecular Mechanisms of Root Gravitropism.

Su SH, Gibbs NM, Jancewicz AL, Masson PH.

Curr Biol. 2017 Sep 11;27(17):R964-R972. doi: 10.1016/j.cub.2017.07.015. Review.

35.

Application of Tetrameric Recombinant Human Butyrylcholinesterase as a Biopharmaceutical for Amelioration of Symptoms of Acute Organophosphate Poisoning.

Terekhov SS, Palikov VA, Palikova YA, Dyachenko IA, Shamborant OG, Smirnov IV, Masson P, Gabibov AG.

Bull Exp Biol Med. 2017 Aug;163(4):430-435. doi: 10.1007/s10517-017-3821-z. Epub 2017 Aug 29.

PMID:
28853097
36.

Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals.

Sautenet B, Tong A, Manera KE, Chapman JR, Warrens AN, Rosenbloom D, Wong G, Gill J, Budde K, Rostaing L, Marson L, Josephson MA, Reese PP, Pruett TL, Hanson CS, O'Donoghue D, Tam-Tham H, Halimi JM, Shen JI, Kanellis J, Scandling JD, Howard K, Howell M, Cross N, Evangelidis N, Masson P, Oberbauer R, Fung S, Jesudason S, Knight S, Mandayam S, McDonald SP, Chadban S, Rajan T, Craig JC.

Transplantation. 2017 Aug;101(8):1875-1886. doi: 10.1097/TP.0000000000001776.

37.

How minimal executive feedback influences creative idea generation.

Ezzat H, Camarda A, Cassotti M, Agogué M, Houdé O, Weil B, Le Masson P.

PLoS One. 2017 Jun 29;12(6):e0180458. doi: 10.1371/journal.pone.0180458. eCollection 2017.

38.

The C5 Variant of the Butyrylcholinesterase Tetramer Includes a Noncovalently Bound 60 kDa Lamellipodin Fragment.

Schopfer LM, Delacour H, Masson P, Leroy J, Krejci E, Lockridge O.

Molecules. 2017 Jun 29;22(7). pii: E1083. doi: 10.3390/molecules22071083.

39.

Bacterial Virus Ontology; Coordinating across Databases.

Hulo C, Masson P, Toussaint A, Osumi-Sutherland D, de Castro E, Auchincloss AH, Poux S, Bougueleret L, Xenarios I, Le Mercier P.

Viruses. 2017 May 23;9(6). pii: E126. doi: 10.3390/v9060126.

40.

Cholinesterase reactivators and bioscavengers for pre- and post-exposure treatments of organophosphorus poisoning.

Masson P, Nachon F.

J Neurochem. 2017 Aug;142 Suppl 2:26-40. doi: 10.1111/jnc.14026. Epub 2017 May 21. Review.

41.

Nanoparticle-Delivered 2-PAM for Rat Brain Protection against Paraoxon Central Toxicity.

Pashirova TN, Zueva IV, Petrov KA, Babaev VM, Lukashenko SS, Rizvanov IK, Souto EB, Nikolsky EE, Zakharova LY, Masson P, Sinyashin OG.

ACS Appl Mater Interfaces. 2017 May 24;9(20):16922-16932. doi: 10.1021/acsami.7b04163. Epub 2017 May 15.

PMID:
28504886
42.

The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age.

Trabado S, Al-Salameh A, Croixmarie V, Masson P, Corruble E, Fève B, Colle R, Ripoll L, Walther B, Boursier-Neyret C, Werner E, Becquemont L, Chanson P.

PLoS One. 2017 Mar 9;12(3):e0173615. doi: 10.1371/journal.pone.0173615. eCollection 2017.

43.

The ins and outs of eukaryotic viruses: Knowledge base and ontology of a viral infection.

Hulo C, Masson P, de Castro E, Auchincloss AH, Foulger R, Poux S, Lomax J, Bougueleret L, Xenarios I, Le Mercier P.

PLoS One. 2017 Feb 16;12(2):e0171746. doi: 10.1371/journal.pone.0171746. eCollection 2017.

44.

Microfluidic droplet platform for ultrahigh-throughput single-cell screening of biodiversity.

Terekhov SS, Smirnov IV, Stepanova AV, Bobik TV, Mokrushina YA, Ponomarenko NA, Belogurov AA Jr, Rubtsova MP, Kartseva OV, Gomzikova MO, Moskovtsev AA, Bukatin AS, Dubina MV, Kostryukova ES, Babenko VV, Vakhitova MT, Manolov AI, Malakhova MV, Kornienko MA, Tyakht AV, Vanyushkina AA, Ilina EN, Masson P, Gabibov AG, Altman S.

Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2550-2555. doi: 10.1073/pnas.1621226114. Epub 2017 Feb 15.

45.

Characterization of butyrylcholinesterase in bovine serum.

Dafferner AJ, Lushchekina S, Masson P, Xiao G, Schopfer LM, Lockridge O.

Chem Biol Interact. 2017 Mar 25;266:17-27. doi: 10.1016/j.cbi.2017.02.004. Epub 2017 Feb 8.

46.

Editorial: Molecular Mechanisms Underlying Polyamine Functions in Plants.

Masson PH, Takahashi T, Angelini R.

Front Plant Sci. 2017 Jan 24;8:14. doi: 10.3389/fpls.2017.00014. eCollection 2017. No abstract available.

47.

[Physical activity of students: prevalence and profiles of associated risk behaviours].

Ladner J, Porrovecchio A, Masson P, Zunquin G, Hurdiel R, Pezé T, Theunynck D, Tavolacci MP.

Sante Publique. 2016 Jun 8;28 Suppl 1:S65-73. French.

PMID:
28155795
48.

Validation of the Patient Global Impression of Improvement for Penile Prosthesis.

Douglas S, Lutz A, McVary KT, Masson P, Winters JC, Laborde E.

Ochsner J. 2016 Winter;16(4):492-495.

49.

Cognition in chronic kidney disease: a systematic review and meta-analysis.

Berger I, Wu S, Masson P, Kelly PJ, Duthie FA, Whiteley W, Parker D, Gillespie D, Webster AC.

BMC Med. 2016 Dec 14;14(1):206. Review.

50.

Chronic Kidney Disease.

Webster AC, Nagler EV, Morton RL, Masson P.

Lancet. 2017 Mar 25;389(10075):1238-1252. doi: 10.1016/S0140-6736(16)32064-5. Epub 2016 Nov 23. Review.

PMID:
27887750

Supplemental Content

Loading ...
Support Center